News

Health-insurance giant Humana is dropping a staggering 550,000 of its less profitable Medicare Advantage customers, or about 10% of the total, this year as it tries to restore its stock price and its ...
StockStory.org on MSN

Why Humana (HUM) Stock Is Up Today

Shares of health insurance company Humana (NYSE:HUM) jumped 1.8% in the afternoon session after Bank of America Securities raised its price target for the company. The firm maintained its "Neutral" ...
Humana, the Louisville-based health insurance company, told its employees on Monday it will close its downtown Humana Building on West Main Street and consolidate its workforce into the Humana ...
Financial giants have made a conspicuous bullish move on Humana. Our analysis of options history for Humana (NYSE:HUM) revealed 9 unusual trades. Delving into the details, we found 44% of traders were ...
Humana is a private insurance company that offers Medicare Advantage with Part D coverage and stand-alone Part D plans. Deductibles, monthly premiums, and drug copays depend on the specific plan.
Humana raised its 2025 guidance alongside the release of second quarter results that beat analyst expectations on Wednesday. It’s a bright spot for investors in the health insurance sector following ...
Humana, the Louisville-based health insurer with an emphasis on Medicare Advantage plans, has announced its new CEO and president will assume the role effective July 1. Previously the company ...
Humana stock has experienced significant fluctuations in recent years, but has historically been able to bounce back after market downturns. However, in 2024, Humana has faced challenges due to rising ...
The healthcare sector is a haven to trade amid market volatility, with the Healthcare sector ETF down only 3.3% YTD compared to the S&P 500's 15% decline. Humana's stock has shown resilience, boosted ...
Bank of America (BofA) raised its price target on Humana to $330 from $312 on Tuesday, pointing to improved sentiment in the ...
Deep-pocketed investors have adopted a bearish approach towards Humana (NYSE:HUM), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this ...